VISTAGEN THERAPEUTICS INC (VTGN) Stock Analyst Ratings
USA - NASDAQ:VTGN - US92840H4002 - Common Stock
3.99 USD
-0.03 (-0.75%)
3.98 USD
-0.01 (-0.25%)
ChartMill assigns a Buy % Consensus number of 87% to VTGN. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 14.79. This target is 270.68% above the current price.
VTGN was analyzed by 11 analysts. The buy percentage consensus is at 87. So analysts seem to be very confident about VTGN.
In the previous month the buy percentage consensus was at a similar level.
VTGN was analyzed by 11 analysts, which is quite many. So the average rating should be quite meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2023-12-07 | Jefferies | Upgrade | Hold -> Buy |
| 2023-11-14 | Stifel | Initiate | Buy |
| 2023-09-05 | Maxim Group | Maintains | Buy -> Buy |
| 2023-08-07 | Maxim Group | Upgrade | Hold -> Buy |
| 2022-07-26 | Maxim Group | Downgrade | Buy -> Hold |
| 2022-07-22 | William Blair | Downgrade | Outperform -> Market Perform |
| 2021-05-20 | Baird | Initiate | Outperform |
| 2021-02-18 | Jefferies | Initiate | Buy |
VISTAGEN THERAPEUTICS INC / VTGN FAQ
What is the price target for VTGN stock?
11 analysts have analysed VTGN and the average price target is 14.79 USD. This implies a price increase of 270.68% is expected in the next year compared to the current price of 3.99.
What is the consensus rating for VISTAGEN THERAPEUTICS INC (VTGN) stock?
The consensus rating for VISTAGEN THERAPEUTICS INC (VTGN) is 87.2727 / 100 . This indicates that analysts generally have a positive outlook on the stock.
What is the number of analysts for VTGN stock?
The number of analysts covering VISTAGEN THERAPEUTICS INC (VTGN) is 11.